KMTS Stock Analysis: Buy, Sell, or Hold?
KMTS - Kestra Medical Technologies, Ltd. Common Stock
$24.76
-1.23 (-4.73%)
▼
5d:
-11.19%
30d:
+27.37%
90d:
+38.56%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jul 14, 2026
0d
Get Alerted When KMTS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: KMTS is down 11.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: KMTS is down 11.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: KMTS is currently trading at $24.76, which is considered slightly high relative to its 30-day fair value range of $19.73 to $26.05.
Technical Outlook: Technically, KMTS is showing sideways momentum. The price is currently testing key support at $24.68. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: KMTS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $27.71 (+11.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KMTS is showing sideways momentum. The price is currently testing key support at $24.68. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: KMTS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $27.71 (+11.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$19.73 -
$26.05
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.1%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading below Wall St target ($27.71)
- WARNING: Recommendation downgraded due to -11.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$19.73 -
$26.05
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$24.69
Resistance Level
$28.81
Current Trend
Sideways
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.57
Wall Street Target
$27.71
(+11.9%)
Revenue Growth (YoY)
62.7%
Profit Margin
-173.0%
Share & Embed Analysis
Last updated: July 13, 2026 11:31 PM ET
Data refreshes hourly during market hours. Next update: 12:31 AM
Data refreshes hourly during market hours. Next update: 12:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KMTS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Brian Daniel Webster
SELL
15000 shares
2026-04-15
Brian Daniel Webster
SELL
15000 shares
2026-03-17
Brian Daniel Webster
SELL
15000 shares
2026-02-17
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$562 | 63 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 61 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$177 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$366 | 63 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$81 | 61 BUY |
